Results 161 to 170 of about 83,390 (218)
Some of the next articles are maybe not open access.

Spinocerebellar ataxias.

Handbook of Clinical Neurology, 2018
There are over 40 autosomal dominant spinocerebellar ataxias (SCAs) now identified. In this chapter we delineate the phenotypes of SCAs 1-44 and dentatorubral-pallidoluysian atrophy (DRPLA) and highlight the clinical and genetic features of the well characterised SCAs in detail in the main section of the chapter, along with their frequency and age at ...
Bing-Wen Soong, Patrick J Morrison
semanticscholar   +3 more sources

Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives

Movement Disorders, 2021
Polyglutamine spinocerebellar ataxias (SCAs) comprise a heterogeneous group of six autosomal dominant ataxias caused by cytosine–adenine–guanine repeat expansions in the coding region of single genes.
Yaimeé Vázquez-Mojena   +4 more
semanticscholar   +1 more source

Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays.

Journal of Neurological Sciences, 2020
Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal dominant inherited diseases that share the degeneration of the cerebellum and its connections as their main feature.
S. S. D. O. Scott   +4 more
semanticscholar   +1 more source

Spinocerebellar ataxias

Neurological Sciences, 2008
Conventional MRI in patients presenting with progressive ataxia demonstrates the three main patterns of macroscopic damage, namely spinal atrophy, olivopontocerebellar atrophy and cortical cerebellar atrophy. Moreover it contributes to the diagnosis of fragile-X tremor ataxia syndrome and siderosis of the CNS.
openaire   +3 more sources

The Spinocerebellar Ataxias

Clinical Neuropharmacology, 2000
The spinocerebellar ataxias (SCAs) are diseases characterized by the progressive degeneration and subsequent loss of neurons accompanied by reactive gliosis, degeneration of fibers from the deteriorating neurons, and clinical symptoms reflecting the locations of the lost neurons.
openaire   +2 more sources

Spinocerebellar ataxia type 20

The Cerebellum, 2005
Spinocerebellar ataxia type 20 (SCA20) was reported in 2004 in a single Australian Anglo-Celtic pedigree. The phenotype is distinctive, with palatal tremor, and hypermetric saccades, and early dentate (but not pallidal) calcification in the absence of abnormalities of calcium metabolism.
Elsdon, Storey   +3 more
openaire   +2 more sources

Spinocerebellar ataxia type 12

2012
SCA12 is a late-onset, autosomal dominant, slowly progressive disorder. Action tremor is the usual presenting sign. Subsequent development of ataxia and hyperreflexia suggests spinocerebellar ataxia. In the index SCA12 kindred, which resides in North America and is of German ancestry, parkinsonism, anxiety, depression, and cognitive dysfunction are not
Elizabeth, O'Hearn   +2 more
openaire   +2 more sources

Spinocerebellar ataxia 7 (SCA7)

Cytogenetic and Genome Research, 2003
Spinocerebellar ataxia 7 (SCA7) is a progressive autosomal dominant neurodegenerative disorder characterized clinically by cerebellar ataxia associated with progressive macular dystrophy. The disease affects primarily the cerebellum and the retina, but also many other CNS structures as the disease progresses.
A-S, Lebre, A, Brice
openaire   +2 more sources

Spinocerebellar ataxia type 1

Seminars in Cell Biology, 1995
Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disorder characterized by ataxia, dysarthria and progressive bulbar dysfunction. The SCA 1 gene which maps to the short arm of chromosome 6 has been isolated using a positional cloning approach. The SCA1 transcript is 10660 bases and encodes a novel protein, ataxin-1, with
H Y, Zoghbi, H T, Orr
openaire   +2 more sources

Spinocerebellar ataxia type 5

2012
In 1994, Ranum and colleagues identified a ten-generation American kindred with a relatively mild autosomal dominant form of spinocerebellar ataxia (Ranum et al., 1994). The mutation was mapped to the centromeric region of chromosome 11, and the disorder designated SCA5 (Ranum et al., 1994). Using a multifaceted mapping approach, Ikeda et al.
Katherine A, Dick   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy